Ugo di Francesco
Direktor/Vorstandsmitglied bei LABOMAR S.P.A.
Profil
Ugo di Francesco is currently a Director at Farmindustria SA, a Non-Executive Director at Labomar SpA, a Director at Chiesi Ltd., a Director at Chiesi SA (Belgium), and a Member of the International Federation of Pharmaceutical Manufacturers.
In the past, he served as the Chief Executive Officer & Vice President at Sigma-Tau Industrie Farmaceutiche Riunite SpA from 2007 to 2011, the Chief Executive Officer & Director at CHIESI Farmaceutici SpA, the Chief Executive Officer at Novartis Consumer Health SpA, a Vice President at Amgen, Inc., a Principal at Novartis sro, and a Vice President at Bristol-Myers Squibb Srl.
Aktive Positionen von Ugo di Francesco
| Unternehmen | Position | Beginn |
|---|---|---|
| LABOMAR S.P.A. | Direktor/Vorstandsmitglied | - |
Chiesi Ltd.
 Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 06.03.2012 |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Direktor/Vorstandsmitglied | - |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | - |
Farmindustria SA
 Farmindustria SA Pharmaceuticals: MajorHealth Technology Farmindustria SA engages in the development, manufacture, and commercialization of pharmaceutical products. These include anti-ulcers, multivitamins, anti-inflammatories, muscle relaxants, neurotonics, and calcium supplements. Its brands include Bonil, Caditar, Flectadol, Hiperflex, Maxucal, Trilat, and Ulcemex. The company was founded in March 1995 and is headquartered in Lima, Peru. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ugo di Francesco
| Unternehmen | Position | Ende |
|---|---|---|
Sigma-Tau Industrie Farmaceutiche Riunite SpA
 Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | Vorstandsvorsitzender | 01.01.2011 |
| AMGEN INC. | Corporate Officer/Principal | - |
Novartis Consumer Health SpA
 Novartis Consumer Health SpA Pharmaceuticals: OtherHealth Technology Part of Novartis AG, Novartis Consumer Health SpA is an Italian company that manufactures and distributes medical drugs. The company is based in Origgio, Italy. | Vorstandsvorsitzender | - |
| Novartis sro | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| LABOMAR S.P.A. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | Health Technology |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Health Technology |
Farmindustria SA
Farmindustria SA Pharmaceuticals: MajorHealth Technology Farmindustria SA engages in the development, manufacture, and commercialization of pharmaceutical products. These include anti-ulcers, multivitamins, anti-inflammatories, muscle relaxants, neurotonics, and calcium supplements. Its brands include Bonil, Caditar, Flectadol, Hiperflex, Maxucal, Trilat, and Ulcemex. The company was founded in March 1995 and is headquartered in Lima, Peru. | Health Technology |
| Novartis sro | |
Chiesi Ltd.
Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Technology |
Novartis Consumer Health SpA
Novartis Consumer Health SpA Pharmaceuticals: OtherHealth Technology Part of Novartis AG, Novartis Consumer Health SpA is an Italian company that manufactures and distributes medical drugs. The company is based in Origgio, Italy. | Health Technology |
Bristol-Myers Squibb SRL
 Bristol-Myers Squibb SRL Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb SRL develops, manufactures and supplies pharmaceuticals. It offers diabetes, oncology, cardiovascular, neuroscience, virology, and immunology services. The company is headquartered in Rome, Italy. | Health Technology |
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Health Technology |
